These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8623451)

  • 1. Reduction in hospital stay after liver transplantation.
    Harrison DM; Stewart AS; Koneru B; Holman MJ
    Transplant Proc; 1996 Apr; 28(2):896. PubMed ID: 8623451
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantation.
    Hashikura Y; Kawasaki S; Matsunami H; Terada M; Ikegami T; Nakazawa Y; Watanabe M; Chisuwa H; Kamijima T; Takagi S; Makuuchi M
    Transplant Proc; 1996 Apr; 28(2):1034-5. PubMed ID: 8623218
    [No Abstract]   [Full Text] [Related]  

  • 3. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract]   [Full Text] [Related]  

  • 6. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
    Ketel BL; Turton-Weeks S; Reed K; Barone GW
    Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR; Platz KP; Berg T; Fukomoto T; Guckelberger O; Neuhaus R; Bechstein WO; Hopf U; Lobeck H; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract]   [Full Text] [Related]  

  • 9. Rejection and hepatitis in liver transplants.
    Manez R; Demetris AJ; Starzl TE
    Transplantation; 1994 Jun; 57(12):1824. PubMed ID: 7517080
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between effects of cyclosporine and tacrolimus on glomerular filtration rate in pediatric post-orthotopic liver transplant patients.
    Loo RM; Ariyarajah V; Oh C; Shen L; Aw MM; Prabhakaran K
    Pediatr Transplant; 2006 Feb; 10(1):55-9. PubMed ID: 16499588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
    Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
    Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary immunosuppression with tacrolimus in kidney transplantation: three-year follow-up in a single center.
    Kim HC; Hwang EA; Han SY; Park SB; Kim HT; Cho WH
    Transplant Proc; 2004 Sep; 36(7):2082-3. PubMed ID: 15518753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation.
    Andrews WS; Sommerauer J; Conlin C; Moore P
    Transplant Proc; 1996 Apr; 28(2):897-8. PubMed ID: 8623452
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
    Wiesner RH
    Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
    [No Abstract]   [Full Text] [Related]  

  • 16. Tacrolimus is superior to cyclosporine in liver transplantation.
    Busuttil RW; Holt CD
    Transplant Proc; 1998 Aug; 30(5):2174-8. PubMed ID: 9723432
    [No Abstract]   [Full Text] [Related]  

  • 17. Usefulness of the switch to tacrolimus in liver transplantation.
    González-Pinto I; Alonso O; Loinaz C; Gómez R; Rodríguez-Cañete A; Rodríguez F; Pérez-Saborido B; Paseiro G; Moreno-González E
    Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653
    [No Abstract]   [Full Text] [Related]  

  • 18. More effective immunosuppression with the use of FK506 after liver transplantation.
    Lo CM; Fan ST; Liu CL; Ng IO; Lam BK; Yong BH; Lai CL; Lau GK; Wong J
    Transplant Proc; 2000 Nov; 32(7):2269-70. PubMed ID: 11120161
    [No Abstract]   [Full Text] [Related]  

  • 19. The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial.
    Lake JR; Gorman KJ; Esquivel CO; Wiesner RH; Klintmalm GB; Miller CM; Shaw BW; Gordon JA
    Transplantation; 1995 Nov; 60(10):1089-95. PubMed ID: 7482713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of immunosuppression on patient outcome after liver transplantation.
    Mueller AR; Platz KP; Willimski C; Berg T; Neuhaus R; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1495-6. PubMed ID: 9636608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.